Cary Street Partners Investment Advisory LLC Innoviva, Inc. Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 12, 2021	SELL	$9.33 - $12.48 $52,714 - $70,512	-5,650 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.33 - $14.49 $58,364 - $81,868	5,650 New	5,650 $59,000

Others Institutions Holding INVA

# of Institutions

228

Shares Held

79.1M

Call Options Held

37.6K

Put Options Held

300

Black Rock Inc. New York, NY

9.63M
Shares

$184 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

7.28M
Shares

$139 Million
34.93% of portfolio
Franklin Resources Inc San Mateo, CA

6.75M
Shares

$129 Million
0.04% of portfolio
Putnam Investments LLC Boston, MA

6.27M
Shares

$120 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

6.23M
Shares

$119 Million
0.0% of portfolio

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account